Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Investor Update - July 18, 2022 Category: Pharmaceuticals Source Type: news
Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Media News - July 18, 2022 Category: Pharmaceuticals Source Type: news
Rwanda Focuses on Health Workers to Strengthen COVID-Related Services in 20 Districts
July 08, 2022Health workers in 20 districts throughout Rwanda are making higher-quality health services related to COVID-19 available to more people in their communities, thanks to training through IntraHealth’s USAID-fundedIngobyi project. Together with the Rwanda Ministry of Health, we are improving the quality and accessibility of services related to family planning, maternal and newborn health, as well as malaria prevention and treatment.“When COVID-19 began to spread in 2020, we had to pivot our preexisting plans and implementation strategies to make sure health workers had the right supplies and training ...
Source: IntraHealth International - July 8, 2022 Category: International Medicine & Public Health Authors: kseaton Tags: Rwanda Ingobyi Family Planning & Reproductive Health Infectious Diseases COVID-19 Malaria Maternal, Newborn, Child Health Health workforce development Global health security Systems Health Workers Source Type: news
‘You get goosebumps from the data’: hopes rise for new malaria vaccine
The disease is a leading killer of under fives across Africa. But trials for a new vaccine suggest an end to the death toll could be in sightWhen Annah Kadhenghi had her first child last year, she named him Brighton Ushindi Baraka:baraka meaning “blessing” in Swahili,ushindi meaning victory. Last month, at the age of seven months, Brighton fought his first battle against an enemy that plagues millions of the world ’s poorest: malaria.“His temperature was very high; he was vomiting. I took him to the hospital,” says Kadhenghi, a schoolteacher in Kilifi, eastern Kenya. Brighton defeated the mosquito-borne disease, ...
Source: Guardian Unlimited Science - June 27, 2022 Category: Science Authors: Lizzy Davies in Kilifi. Photography by Luis Tato for the Guardian Tags: Malaria Global development Kenya Africa World news Vaccines and immunisation Infectious diseases Health Medical research Source Type: news
GSK announces £1 billion R & D investment over ten years to get ahead of infectious diseases in lower-income countries
GSK plc (LSE/NYSE: GSK) announced an investment of £1bn over ten years to accelerate research and development (R&D) dedicated to infectious diseases that disproportionately impact lower-income countries.
This research will focus on new and disruptive vaccines and medicines to prevent and treat malaria, tuberculosis, HIV (through ViiV Healthcare), neglected tropical diseases (NTDs), and anti-microbial resistance (AMR), (Source: World Pharma News)
Source: World Pharma News - June 23, 2022 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
Stronger Healthcare Systems Critical for Africa ’s Socioeconomic Transformation
As Africa rebuilds following the pandemic, investment in the fight against malaria and NTDs will make healthcare systems more resilient and support longer-term pandemic preparedness. Credit: UNDP Kenya/James OchweriBy Claude Mambo MuvunyiKIGALI, Jun 22 2022 (IPS) Since the outbreak of the COVID-19 pandemic, healthcare systems globally have battled to deal with the repercussions unleashed by the disease. From the outset, Africa was considered particularly vulnerable due to several factors: limited healthcare provision in some areas, high prevalence of HIV and TB in a number of countries, and limited fiscal room to respond t...
Source: IPS Inter Press Service - Health - June 22, 2022 Category: International Medicine & Public Health Authors: Claude Mambo Muvunyi Tags: Africa Headlines Health Poverty & SDGs TerraViva United Nations Source Type: news
President Kenyatta: We need vaccines and investment to tip the scales against malaria
After years in retreat, the disease is once again on the rise across the continent (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 20, 2022 Category: Pharmaceuticals Source Type: news
African Solutions to African Problems: Reframing Science Innovation
Through collaboration we can build on the foundations of our knowledge to bring forward innovative ways to address health challenges that benefit all of humanity. Credit: WHOBy Quarraisha Abdool KarimDURBAN, South Africa, Jun 8 2022 (IPS) Africa is plagued by many epidemics — from tuberculosis and HIV/AIDS to malaria and wild polio — but the continent has also worked for decades to fight these threats. The key to beating these deadly diseases is turning inward to existing expertise and finding locally driven solutions.
The recent COVID-19 pandemic has placed public health back in the global spotlight and has also serve...
Source: IPS Inter Press Service - Health - June 8, 2022 Category: International Medicine & Public Health Authors: Quarraisha Abdool Karim Tags: Africa Headlines Health Poverty & SDGs TerraViva United Nations Source Type: news
Bill Gates Says the World Got Lucky With COVID-19: ‘It Could Have Been Way More Fatal’
The cost of the COVID-19 pandemic is staggering, in terms of both human life and and economic activity. But Bill Gates believes humanity is fortunate that the virus was not even more devastating.
“I have to say, given the toll of this pandemic 20 million dead globally, a million in the U.S., and it could have been way more fatal. We just got lucky that the death rate per case was like 0.2%,” Gates told TIME senior correspondent Alice Park during the TIME 100 Summit in New York City on Tuesday.
While the official global death toll from COVID-19 is about 6.3 million, experts estimate that the real number of death...
Source: TIME: Health - June 7, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 nationpod News sponsorshipblock TIME100 Summit 2022 time1002022 Source Type: news
Africa: Findings On Malaria Immunity Could Help Vaccine Development
[SciDev.Net] Nairobi -- Understanding how people exposed to malaria for the first time develop immunity could lead to creating more effective treatments including vaccines to fight the disease, researchers say. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - June 4, 2022 Category: Infectious Diseases Source Type: news
Rwanda: Rwanda in Talks to Acquire Malaria Vaccine
[New Times] Rwanda is taking part in discussions with several international stakeholders, as part of efforts for the country to acquire the malaria vaccine. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - May 30, 2022 Category: Infectious Diseases Source Type: news
It Took 35 Years to Get a Malaria Vaccine. Why? It Took 35 Years to Get a Malaria Vaccine. Why?
The parasite ' s complex biology played a role in the delay, but experts say there was also a lack of urgency and funding.Undark (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 25, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Now is the Time to Address the Global Health Equity Gap
While the world has been preoccupied with COVID-19, deaths from non-communicable diseases (NCDs) continue to impact poor nations at an alarming rate. Each year around the world, more than 15 million people die from NCDs between the ages of 30 and 69, and 85% of these premature deaths occur in low- and middle-income countries. In fact, more people die from cancer in Africa than from malaria. Yet, many of the latest cancer treatments have not yet reached lower income countries. While treatments for all of these conditions exist, the barriers that keep them from patients are persistent and complex.
[time-brightcove not-tgx=&#...
Source: TIME: Health - May 25, 2022 Category: Consumer Health News Authors: Albert Bourla Tags: Uncategorized COVID-19 Source Type: news
As COVID Wanes, Tuberculosis Deaths Must Become Visible
Tuberculosis has killed 1,5 million people in 2020 - mostly in African and Asian countries - while two million people died of COVID-19 worldwide during the same period. Credit: Athar Parvaiz/IPSBy Angelique Luabeya Kany KanyCAPE TOWN, South Africa, May 19 2022 (IPS) It is time to treat the scourge of Tuberculosis scourge with the same urgency as we did the COVID-19 pandemic.
As we emerge from the devastating toll of the pandemic on people’s lives and on global economies, we must wake up to face the staggering toll of 1.5 million Tuberculosis deaths and 10 million new infections recorded in 2020. And these deaths wer...
Source: IPS Inter Press Service - Health - May 19, 2022 Category: International Medicine & Public Health Authors: Angelique Luabeya Kany Kany Tags: Africa Headlines Health Poverty & SDGs TerraViva United Nations tuberculosis Source Type: news
Africa: World's First Malaria Vaccine Coming to Nigeria, Others in Sub-Saharan Africa
[Vanguard] On the heels of its success in Ghana, Kenya and Malawi, there are strong indications that the world's first malaria vaccine will soon be available in Nigeria and across Sub-Saharan Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 10, 2022 Category: African Health Source Type: news
